Statistical Analysis
We first used unconditional logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for risk of DLBCL with each exposure variable, adjusted for age, sex, race/ ethnicity, and study ("basic adjusted models"). The statistical significance of each relationship was evaluated by a likelihood ratio test, comparing models with and without the exposure variable of interest, with P values less than .05 identifying putatively influential factors. Individuals with missing data for the exposure variable of interest were excluded. To evaluate effect heterogeneity among the 19 studies, we performed a separate logistic regression within each study and then quantified the variability of the coefficients by the H statistic, adapting the definition by Higgins and Thompson to categorical variables (28) .
To consider possible effect modification, we repeated the above logistic regression analyses stratified by sex and age (<60 and 60+ years). We tested for effect heterogeneity by calculating the Wald statistic for the interaction term between each exposure and stratification variable. We also evaluated heterogeneity using forest plots by study design characteristics. Finally, we conducted an exploratory analysis of selected anatomical sites, modeling risk of DLBCL at a specific anatomical site (excluding all other DLBCL cases), adjusted for age, sex, race/ethnicity, and study.
To build a multivariate model for DLBCL, we reviewed the basic adjusted models and then selected the best variable within a given class of related variables to move forward to stepwise regression. A variable was selected after considering the effect size (i.e., stronger OR), exposure prevalence (e.g., choosing either a summary variable or a more common exposure over a rarer one to maximize power), and P value. From this set of selected factors, we evaluated the correlations of these variables as well as the risk estimate for each factor in a series of models that adjusted for other risk factors individually as well as age, race/ethnicity, sex, and study. We then conducted a single logistic regression model including all the selected risk factors, this time including a separate missing category for each variable to ensure that the entire study population was included in the analysis (i.e., not dropped due to missing data). Finally, we conducted a forward stepwise logistic regression with all the selected risk factors, adjusting for age, sex, race/ethnicity, and study; the risk factors remaining in this model were considered to be independent of each other ("final stepwise model"). We conducted these analyses for the entire study population, then separately for men and women. Because of small sample sizes, we did not conduct stepwise logistic regression for DLBCL site-specific analyses. All analyses were conducted using SAS software, version 9.2 (SAS Institute, Inc, Cary, NC).
Results
The pooled study population included 4667 DLBCL cases and 22 639 controls from 19 InterLymph studies; full characteristics are provided in Table 1 . As has been previously noted for DLBCL (1, 2) , the percentage of men (55.2%) was higher than that for women (44.8%). Controls for most studies were chosen to approximate the age and sex distribution of all lymphoma cases, leading to some imbalance of the age and sex distribution for the controls used in this analysis. In a sensitivity analysis, we used a subset of controls that were frequency matched by age and sex to the DLBCL cases, which produced similar results to those obtained using the full set of controls (data not shown). Therefore, we retained the full set of controls for our main analyses to increase statistical power.
Overall and Sex-and Age-Specific Associations From the Basic Adjusted Models
The basic adjusted model results are shown in Supplementary  Table 1 . The variables selected for incorporation into the final stepwise models (bolded in Supplementary Table 1) included socioeconomic status (SES); B/T-cell activating autoimmune diseases (selected from a group of 18 autoimmune variables, which also included positive associations for Sjögren syndrome, systemic lupus erythematosus, hemolytic anemia, celiac disease, and rheumatoid arthritis); history of any atopic disorder (selected from six atopy variables, which also included inverse associations with allergy, food allergy, asthma, and hay fever); hepatitis C virus (HCV) seropositivity; history of blood transfusion (selected from five transfusion variables); family history of NHL (selected from 15 family history variables, which also included positive associations with family history of any hematologic malignancy and Hodgkin lymphoma); usual and young adult body mass index (BMI) (selected from three anthropometric variables, which also included a positive association with weight); lifetime alcohol use (selected from 16 variables, the majority of which showed inverse associations by current status, type, intensity and duration of use); recreational sun exposure; and occupation as a cleaner/related worker, driver/material handling equipment operator, field crop and vegetable farmer, women's hairdresser, medical worker, and seamstress/embroiderer. There were no associations with cigarette smoking (from seven variables), physical activity, personal hair dye use (from six variables), or ever having lived or worked on a farm.
We also conducted sex-stratified analyses (including a test for interaction) for all of the basic associations that were reported in Supplementary Table 1 to identify variables to include in the sexspecific stepwise regression models. For women, additional variables were pack-years of smoking, oral contraceptive (OC) use by year started, and age at start of hormone therapy (HT) use. For men, the only additional variable was occupation as a metal processer. Variables selected for the stepwise models with evidence for sex-specific heterogeneity included blood transfusion (P = .046), young adult BMI (P = .023), and lifetime alcohol consumption (P = .0029), all of which showed stronger associations for men than for women (Supplementary Table 1 ). There was no strong evidence of heterogeneity by age for variables in Supplementary Table 1 (data not shown).
Heterogeneity by Design Variables
In reviewing the H statistic from each of the basic adjusted models, only recreational sun exposure (H = 2.44, 95% CI = 1.11 to 5.34) and adult BMI (H = 2.42, 95% CI = 1.31 to 4.48) showed substantial heterogeneity. In further reviewing forest plots for these two variables as well as other variables selected for the final stepwise models, a majority showed no evidence for heterogeneity by study design (i.e., population-based versus hospital-/clinic-based), World Health Organization versus Working Formulation, location (North America, Northern Europe, Southern Europe, Australia), or specific study. However, there was some suggestion that the associations with adult BMI (Supplementary Figure 1) , OC use before 1970 (Supplementary Figure 2) , and seamstresses/embroiders (Supplementary Figure 3) were strongest in North American studies; autoimmune disease (Supplementary Figure 4) was strongest in population-based studies; and recreational sun exposure (Supplementary Figure 5) was strongest in Australia and Southern Europe.
Final Stepwise Models
The final stepwise model for all participants (Table 2) ; greater lifetime alcohol consumption (OR = 0.64 for >400 kg vs nondrinker); higher recreational sun exposure (OR = 0.78); and occupation as field crop and vegetable farmer (OR = 1.49), seamstress/embroiderer (OR = 1.43), and driver/material handling equipment operator (OR = 1.47). These results were consistent in pairwise adjusted models of all exposure variables, as well as the model simultaneously adjusting for all exposures, further supporting that the effects of these variables were mutually independent.
We next conducted sex-specific stepwise models (Table 2) . For both sexes, SES, autoimmune disease B-/T-cell type, atopic disorder, HCV seropositivity, family history of NHL, young adult BMI, (Table continues ) and recreational sun exposure were retained in the final models with similar ORs for men and women. , and occupation as field crop/vegetable farm worker (OR = 1.78), seamstress/ embroiderer (OR = 1.49), and women's hairdresser (OR = 1.65) were also retained in the final model; pack-years of smoking was not retained. For men, blood transfusion (OR = 0.69), lifetime alcohol consumption (OR = 0.57 for >400 kg vs nondrinker), and occupation as a driver/material handling equipment operator (OR = 1.58) were retained in the final model; metal processer was not retained.
Site-Specific Results
We next evaluated how the variables used in the final model (Table 2) , excluding the occupation and reproductive variables (due to low exposure prevalence), performed for selected anatomical sites that may have distinct epidemiological or clinical characteristics, including CNS (N = 103), GI (N = 323), testis (N = 44), cutaneous (N = 120), and primary mediastinal (N = 91) DLBCL (Table 3 ). In addition, we reported any additional variables from Supplementary Table 1 that were significant at P value less than .05 for a specific site. Due to small sample sizes, we treated these as exploratory analyses and did not conduct formal heterogeneity tests. Even in this exploratory setting, we observed some notable patterns. CNS DLBCL was inversely associated with atopic disorder (OR = 0.54) and OC use before 1970 (OR = 0.19) and was positively associated with family history of NHL (OR = 4.11) and pack-years of smoking (OR = 1.52 for >35 pack-years versus nonsmoker). * Odds ratio (OR) and 95% confidence interval (CI) adjusted for age, sex, race/ethncity, study, and other factors in the same column. BMI = body mass index; HCV = hepatitis c virus; HT = hormone therapy; NHL = non-Hodgkin lymphoma; OC = oral contraceptive; SES = socioeconomic status. † Includes self-reported history of specific autoimmune diseases occurring ≥2 years before diagnosis/interview (except the New South Wales study, which did not ascertain date of onset). Autoimmune diseases were classified according to whether they are primarily mediated by B-cell or T-cell responses. B-cell activating diseases included Hashimoto thyroiditis, hemolytic anemia, myasthenia gravis, pernicious anemia, rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. T-cell activating diseases included celiac disease, immune thrombocytopenic purpura, inflammatory bowel disorder (Crohn's disease, ulcerative colitis), multiple sclerosis, polymyositis or dermatomyositis, psoriasis, sarcoidosis, systemic sclerosis or scleroderma, and type 1 diabetes. ‡ Includes self-reported history of atopic disorders including asthma, eczema, hay fever, or other allergies, excluding drug allergies, occurring ≥2 years before diagnosis/interview (except the New South Wales study, which did not ascertain date of onset). § Study specific quartiles among controls. . --* Odds ratio (OR) and 95% confidence interval (CI) adjusted for age, sex, race/ethnicity, and study. BMI = body mass index; CNS = central nervous system; HCV = hepatits C virus; GI = gastrointestinal; HT = hormone therapy; NHL = non-Hodgkin lymphoma; OC = oral contraceptive; SES = socioeconomic status. † Includes self-reported history of specific autoimmune diseases occurring ≥2 years before diagnosis/interview (except the New South Wales study, which did not ascertain date of onset). Autoimmune diseases were classified according to whether they are primarily mediated by B-cell or T-cell responses. B-cell activating diseases included Hashimoto thyroiditis, hemolytic anemia, myasthenia gravis, pernicious anemia, rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. T-cell activating diseases included celiac disease, immune thrombocytopenic purpura, inflammatory bowel disorder (Crohn's disease, ulcerative colitis), multiple sclerosis, polymyositis or dermatomyositis, psoriasis, sarcoidosis, systemic sclerosis or scleroderma, and type 1 diabetes. ‡ Includes self-reported history of atopic disorders including asthma, eczema, hay fever, or other allergies, excluding drug allergies, occurring ≥2 years prior to diagnosis/interview (except the New South Wales study, which did not ascertain date of onset). § Study specific quartiles among controls. a farm (OR = 3.12), and hair dye use duration (OR = 4.97 for 20+ years versus never). Although none of the risk factors was unambiguously associated with all of these sites, there were consistent trends for family history for all sites, autoimmune disease for all sites except CNS, atopic disorders for all sites except cutaneous, young adult BMI for all sites except cutaneous.
Discussion
Our study provides strong evidence that many DLBCL risk factors previously recognized but assessed individually are independent of each other, supporting a complex and multifactorial etiology. Specifically, B-cell activating autoimmune diseases, HCV seropositivity, family history of NHL, and higher young adult BMI were associated with increased DLBCL risk, whereas higher SES, any atopic disorder, and greater recreational sun exposure were associated with decreased risk. Some risk factors were sex specific: OC use before 1970, HT use starting at age at least 50 years, and low usual adult BMI were all inversely associated with risk among women, whereas previous blood transfusion and lifetime alcohol consumption were both inversely associated with risk among men. Occupational associations were largely sex specific. Several notable findings emerged from this analysis. Perhaps the most prominent was the robust link to risk factors associated with immune function, given the strong and independent associations of B-cell activating autoimmune diseases and HCV seropositivity with DLBCL risk, both of which mechanistically implicate chronic immune stimulation (14, 16) . In contrast, the immune impact of atopic disorders (with characteristic hypersensitivity reactions and associated release of inflammatory molecules) appears to play a role in decreasing DLBCL risk (18) . The independent effects of each of these factors based on our multivariate results support a complex interaction of immune system function and DLBCL risk, which requires further research to understand the underlying mechanisms.
A second notable finding was the positive and independent association of young adult BMI with DLBCL risk, which was the same for both sexes. Although young adult BMI and usual adult BMI were correlated, 51% of the controls moved to a different BMI category (mainly gain) and with our large sample size we were able to model both simultaneously. The consistency of our findings with most previous data from cohort studies (29-34) strongly supports the robustness of excess body weight with DLBCL at younger ages, with implications for primary prevention. Whether BMI impacts DLBCL risk through immune, hormonal, or another mechanism remains to be determined (35) . A role for hormonal factors was also supported by the protective effects of both OC and HT use in women, although positive impacts on immune function are also plausible (19) .
The inverse association of sunlight with DLBCL risk was independent of physical activity, BMI, and other lifestyle factors including alcohol use. Basic biological and some epidemiological evidence suggests that either vitamin D or UV-induced immune alterations independent of vitamin D could be responsible for the observed inverse association (36) (37) (38) (39) , although circulating serum vitamin D levels evaluated a median of 5 years before DLBCL diagnosis were not associated with risk in a large pooling project (36) . UV radiation induction of regulatory T cells also is plausible but requires further investigation (40, 41) . Studies using intermediate biomarkers of exposure or effect will be needed to sort out this hypothesis.
An inverse association with transfusion history, significant only for men, will be more fully reported in a separate InterLymph publication; the findings here extend this association as independent of other immune and lifestyle factors. The inverse association is difficult to interpret in light of previous studies, which support a positive association (42) , and raises concerns about bias or chance as primary explanations.
Many of the occupations associated with increased DLBCL risk may be related to carcinogenic exposures, but we were unable to pinpoint specific agents; likely candidates include pesticides, solvents, dyes, engine exhausts, wood dust and wood finishing chemicals, and microbes and other biological agents (43) (44) (45) (46) (47) . Occupational associations were generally sex specific, and this may be due to actual exposure for men and women in the same jobs having different exposure levels or exposure patterns (48, 49) . A limitation of occupational titles is the high potential for misclassification of exposure status, which can dilute risk estimates.
Our finding of an increased DLBCL risk with family history of NHL was robust even when adjusted for other identified DLBCL risk factors. This is particularly relevant because family history reflects an interaction between shared exposures (both from shared environment and behaviors) and genetic susceptibility. The association between family history of NHL and DLBCL risk was not attenuated, and was even strengthened, by inclusion of environmental and lifestyle factors, suggesting that heritability is an independent risk factor for DLBCL. Further analyses are warranted to determine whether established genetic associations are independent of family history, or whether they help explain in part the association between family history of NHL and DLBCL.
We found little evidence for heterogeneity when we stratified these associations by age at diagnosis (<60 versus 60+ years), noting that 70% of the cases were aged 50-79 years at diagnosis, perhaps limiting our ability to identify age-related differences.
We aimed to explore whether risk factors identified for all DLBCL were common to selected sites (see Table 3 ), each of which has a somewhat unique descriptive (6-10) but little published risk factor epidemiology. For primary CNS lymphoma, the only established risk factors are congenital and acquired immunodeficiency (particularly HIV disease, which we excluded) (7). Consistent with the only comparable case-control study (50) were our observations of an inverse association with OC use, positive associations with family history of NHL and smoking, and null associations for farming and transfusion history; an inverse association with atopy in our study was null in that study, whereas we did not examine autoimmune disease (only six exposed cases) and did not assess tonsillectomy, reported to reduce risk in the previous study. For GI lymphoma, of which DLBCL is the most common histology (9,51), transplantation, HIV infection, and ulcerative colitis have been suggested as risk factors (52); we excluded HIV patients, whereas the reported association with ulcerative colitis is consistent with our finding for inflammatory bowel disease.
Autoimmune disease, atopy, family history of NHL, and perhaps young adult BMI showed consistent risk patterns across anatomical sites, supporting a shared etiology. Intriguing site-specific patterns included associations for smoking with CNS, testicular and cutaneous DLBCL; inflammatory bowel disease with GI DLBCL; and ever having lived on a farm and hair dye use with mediastinal DLBCL. These findings suggest consideration of unique pathogenic mechanisms such as local inflammatory mechanisms in GI DLBCL and chemical exposure for mediastinal DLBCL. The approximately fourfold increase in CNS and mediastinal DLBCL risk with family history of NHL may suggest that heritability and genetics play even larger roles in these presentations. Nevertheless, caution is needed in interpreting these results due to small number of cases in these analyses, difficulty of diagnosing these rare entities, and the complexity of assigning a primary site for NHL in epidemiological studies. Furthermore, heterogeneity within some of the extranodal sites, particularly mediastinal (which will include true DLBCL but also primary mediastinal B-cell lymphoma), cutaneous (e.g., leg type versus other), and GI tract (e.g., some gastric cases are likely to be associated with Helicobacter pylori infection), could not be assessed.
Strengths specific to this analysis (beyond those of the entire initiative) (22) included the largest sample size of DLBCL cases yet assembled for a risk factor analysis and availability of data on anatomical sites. Specific limitations include the lack of data on DLBCL cell of origin (which may have unique etiologies) (11) and limited power to perform site-specific analyses. We did not adjust our results for multiple comparisons, although most of these exposures had a strong a priori probability. We had few cases above the age of 80 years, although this age group has the highest DLBCL incidence rates. Our analyses excluded HIV-associated DLBCL. Assignment to anatomical sites was limited to those studies that coded this information independent of stage. Beyond HCV, we did not have information on other infections. It will be important for future epidemiological studies to incorporate biological specimens to help elucidate the mechanisms underlying many of these observed associations.
In summary, this large pooled analysis has clarified multiple risk factors for DLBCL and has demonstrated that many previously reported factors act independently on DLBCL risk. These new findings will need to be incorporated into models of DLBCL epidemiology and pathogenesis, and support a complex biology that includes familial, medical, lifestyle, and occupational factors.
